NSE Stock Draws Rare ‘Sell’ Call Ahead of Long-Awaited IPO Debut
THE SO WHAT
A rare sell rating on India’s National Stock Exchange just before what could be the country’s largest IPO is a reminder that even core market infra can be priced for perfection. If you’re timing a listing off momentum alone, assume coverage will normalize expectations faster than in the last cycle.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureManipal Hospitals Said to Cut Valuation to $8.3 Billion in IPO
A flagship Indian hospital chain trimming its IPO ask to about $8.3 billion is another data point that healthcare assets are not immune to valuation discipline. If you’re planning a listing in the next 6–12 months, assume investors will push harder on cash flow quality and regulatory risk, not just growth stories.
Startups & VentureSoftBank Plans New ¥60 Billion Bond After Retail, Overseas Deals
SoftBank tapping institutional yen investors for another ¥60 billion after retail and foreign-currency rounds shows it still prefers leverage over equity to fund its pipeline. For founders and GPs, that means the SoftBank capital machine remains active — but you should underwrite the interest-rate and refinancing risk behind any long-dated support.
Startups & VentureThe sectors with the most momentum heading into H2
Sector momentum pieces are effectively a proxy for where capital and hiring will concentrate over the next 6–12 months. Use them as a sanity check against your own pipeline and roadmap assumptions, not as a shopping list for pivots.
Startups & VentureEoptolink Is Said to File for Up to $5 Billion Hong Kong Listing
A potential $5B Hong Kong listing for an optical transceiver maker underlines how AI demand is pulling networking components into the capital markets spotlight. If your infra depends on high-speed optics, treat supplier concentration and China exposure as a strategic risk, not a procurement detail.